X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7228) 7228
Book Review (435) 435
Publication (238) 238
Newsletter (27) 27
Conference Proceeding (21) 21
Dissertation (20) 20
Book Chapter (6) 6
Magazine Article (6) 6
Newspaper Article (3) 3
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5868) 5868
humans (5647) 5647
female (4508) 4508
middle aged (3659) 3659
epirubicin - administration & dosage (3395) 3395
oncology (3347) 3347
epirubicin (3319) 3319
antineoplastic combined chemotherapy protocols - therapeutic use (2961) 2961
adult (2945) 2945
aged (2942) 2942
male (2286) 2286
chemotherapy (2219) 2219
breast neoplasms - drug therapy (2076) 2076
cancer (1481) 1481
treatment outcome (1418) 1418
breast cancer (1367) 1367
fluorouracil - administration & dosage (1326) 1326
doxorubicin (1305) 1305
cyclophosphamide - administration & dosage (1274) 1274
antineoplastic combined chemotherapy protocols - adverse effects (1218) 1218
breast neoplasms - pathology (1122) 1122
epirubicin - adverse effects (989) 989
antineoplastic combined chemotherapy protocols - administration & dosage (925) 925
cisplatin - administration & dosage (915) 915
epirubicin - therapeutic use (892) 892
therapy (870) 870
chemotherapy, adjuvant (843) 843
anthracyclines (840) 840
cyclophosphamide (824) 824
neoplasm staging (785) 785
drug administration schedule (779) 779
disease-free survival (744) 744
cisplatin (725) 725
prognosis (698) 698
doxorubicin - administration & dosage (697) 697
combined modality therapy (684) 684
survival rate (675) 675
paclitaxel (663) 663
carcinoma (647) 647
pharmacology & pharmacy (627) 627
antibiotics, antineoplastic - administration & dosage (577) 577
animals (572) 572
docetaxel (565) 565
survival analysis (564) 564
fluorouracil (552) 552
survival (552) 552
follow-up studies (541) 541
paclitaxel - administration & dosage (523) 523
medicine & public health (514) 514
trial (511) 511
neoadjuvant therapy (491) 491
care and treatment (490) 490
prospective studies (489) 489
retrospective studies (485) 485
epirubicin - pharmacology (482) 482
dose-response relationship, drug (480) 480
aged, 80 and over (471) 471
adjuvant chemotherapy (446) 446
taxoids - administration & dosage (445) 445
breast neoplasms - surgery (424) 424
surgery (420) 420
neoadjuvant chemotherapy (405) 405
research (396) 396
breast neoplasms - mortality (395) 395
time factors (390) 390
stomach neoplasms - drug therapy (375) 375
adenocarcinoma - drug therapy (374) 374
tumors (372) 372
antineoplastic agents - therapeutic use (369) 369
analysis (360) 360
neoplasm metastasis (358) 358
5-fluorouracil (352) 352
cyclophosphamide - adverse effects (345) 345
adolescent (339) 339
drug therapy (338) 338
deoxycytidine - analogs & derivatives (334) 334
antibiotics, antineoplastic - therapeutic use (329) 329
phase-ii (324) 324
methotrexate - administration & dosage (321) 321
doxorubicin - adverse effects (317) 317
toxicity (311) 311
fluorouracil - adverse effects (309) 309
adriamycin (307) 307
doxorubicin - therapeutic use (299) 299
methotrexate (299) 299
health aspects (294) 294
cell line, tumor (290) 290
mice (290) 290
combination (288) 288
antibiotics, antineoplastic - adverse effects (287) 287
etoposide - administration & dosage (285) 285
randomized-trial (285) 285
deoxycytidine - administration & dosage (282) 282
risk factors (282) 282
lymphatic metastasis (281) 281
liver neoplasms - drug therapy (280) 280
remission induction (280) 280
cyclophosphamide - therapeutic use (279) 279
antineoplastic agents - administration & dosage (278) 278
breast-cancer (278) 278
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6395) 6395
Japanese (367) 367
Chinese (164) 164
German (112) 112
French (87) 87
Italian (52) 52
Spanish (28) 28
Russian (26) 26
Polish (20) 20
Hungarian (13) 13
Korean (9) 9
Portuguese (5) 5
Bulgarian (4) 4
Romanian (4) 4
Serbian (4) 4
Danish (3) 3
Czech (2) 2
Croatian (1) 1
Finnish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Investigational New Drugs, ISSN 0167-6997, 06/2017, Volume 35, Issue 3, pp. 307 - 314
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2015, Volume 218, pp. 36 - 44
To develop a biodegradable polymeric drug delivery system for the treatment of ovarian cancer with the capacity for non-invasive fate monitoring, we designed... 
N-(2-hydroxypropyl)methacrylamide (HPMA) | FRET | Epirubicin | Ovarian carcinoma | VIVO | COMBINATION THERAPY | DOXORUBICIN | POLYMERIZATION | CANCER | CHEMISTRY, MULTIDISCIPLINARY | GEMCITABINE | DELIVERY | PACLITAXEL | N-(2-hydroxypropyl) methacrylamide (HPMA) | MULTIBLOCK | PHARMACOLOGY & PHARMACY | Carbocyanines - chemistry | Antibiotics, Antineoplastic - pharmacology | Carbocyanines - administration & dosage | Humans | Ovarian Neoplasms - pathology | Carbocyanines - pharmacology | Epirubicin - administration & dosage | Methacrylates - chemistry | Methacrylates - therapeutic use | Antibiotics, Antineoplastic - chemistry | Fluorescence Resonance Energy Transfer | Methacrylates - pharmacology | Female | Fluorescent Dyes - pharmacology | Ovarian Neoplasms - metabolism | Fluorescent Dyes - administration & dosage | Ovarian Neoplasms - drug therapy | Cell Survival - drug effects | Fluorescent Dyes - chemistry | Epirubicin - chemistry | Methacrylates - administration & dosage | Antibiotics, Antineoplastic - administration & dosage | Animals | Antibiotics, Antineoplastic - therapeutic use | Tumor Burden - drug effects | Mice, Nude | Cell Line, Tumor | Epirubicin - therapeutic use | Mice | Epirubicin - pharmacology | Polymerization | Care and treatment | Anthracyclines | Carcinoma | Cancer | Ovarian cancer | Index Medicus | N-(2-Hydroxypropyl)methacrylamide (HPMA)
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2017, Volume 523, Issue 1, pp. 203 - 216
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2017, Volume 258, pp. 95 - 107
Multimodal imaging-guided synergistic combination therapy has shown great potential for cancer treatment. However, the nanocarrier-based theranostic systems... 
Indocyanine green | Epirubicin | Co-self-assembly | Dual-modal imaging | Combination chemo-photothermal therapy | Small molecular nanodrugs | PHOTODYNAMIC THERAPY | COMBINATION THERAPY | CARRIER-FREE | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | DELIVERY | TUMOR ACCUMULATION | MULTIFUNCTIONAL NANOPARTICLES | IN-VIVO | PHARMACOLOGY & PHARMACY | PURE NANODRUGS | Nanoparticles - chemistry | Humans | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Breast Neoplasms - therapy | Indocyanine Green - chemistry | Phototherapy - methods | Theranostic Nanomedicine - methods | MCF-7 Cells | Nanoparticles - therapeutic use | Photoacoustic Techniques - methods | Female | Breast Neoplasms - diagnostic imaging | Hyperthermia, Induced - methods | Optical Imaging - methods | Coloring Agents - administration & dosage | Epirubicin - chemistry | Indocyanine Green - administration & dosage | Models, Molecular | Antineoplastic Agents - chemistry | Animals | Mice, Nude | Cell Line, Tumor | Epirubicin - therapeutic use | Combined Modality Therapy - methods | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Drug Delivery Systems - methods | Coloring Agents - chemistry | Drugs | Nanoparticles | Chemotherapy | Anthracyclines | Drug delivery systems | Fluorescence | Pharmaceutical industry | Drug approval | Vehicles | Cancer | Index Medicus
Journal Article
5-Fluorouracil, Epirubicin and Cisplatin in the Treatment of Metastatic Gastric Carcinoma: A Retrospective Analysis of 68 Patients, 12/2005
BACKGROUND: Gastric cancer is one of the most common types of cancer and one of the most frequent causes of cancer-related death. The majority of gastric... 
Metastatic gastric cancer, 5-Fluorouracil, Epirubicin, Cisplatin
Journal
Cancer Letters, ISSN 0304-3835, 2012, Volume 330, Issue 1, pp. 74 - 83
Abstract Multidrug resistance (MDR) is one of the major reasons for the failure of cancer chemotherapy. A newly reported liposome carrier, propylene glycol... 
Hematology, Oncology and Palliative Medicine | Cancer targeted therapy | Propylene glycol liposomes | Epirubicin | Multidrug resistance | TUMOR-CELL LINES | DRUG | VITRO | METASTASIS | BIODISTRIBUTION | DELIVERY | REVERSAL | PLURONIC L61 | TRANSPORT | ONCOLOGY | IN-VIVO | Antibiotics, Antineoplastic - pharmacology | Drug Resistance, Multiple | Liposomes - administration & dosage | Humans | Drug Resistance, Neoplasm | Epirubicin - administration & dosage | Mammary Neoplasms, Experimental - metabolism | Breast Neoplasms - metabolism | Propylene Glycol - administration & dosage | Antibiotics, Antineoplastic - chemistry | Mammary Neoplasms, Experimental - pathology | Female | Antibiotics, Antineoplastic - pharmacokinetics | Propylene Glycol - chemistry | Mammary Neoplasms, Experimental - drug therapy | Cell Growth Processes - drug effects | Epirubicin - chemistry | Rats | Random Allocation | Breast Neoplasms - drug therapy | Rats, Sprague-Dawley | Antibiotics, Antineoplastic - administration & dosage | Liposomes - chemistry | Animals | Breast Neoplasms - pathology | Cell Line, Tumor | Epirubicin - pharmacokinetics | Epirubicin - pharmacology | Drug resistance in microorganisms | Anthracyclines | Fluorescence | Breast cancer | Permeability | Cells | Membrane proteins | Propylene | Prevention | Chemotherapy | Analysis | Physiological aspects | Health aspects | Cancer | Proteins | Nanoparticles | Cell growth | Efficiency | Science | Laboratory animals | Retention | Cancer therapies | Cholesterol | Index Medicus
Journal Article
Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 04/2015, Volume 128, pp. 448 - 456
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2018, Volume 36, Issue 10, pp. 1045 - 1046
Journal Article
Journal Article